"Fakultní nemocnice Olomouc je jedním z největších lůžkových zařízení v České republice. Je součástí sítě jedenácti fakultních nemocnic přímo řízených Ministerstvem zdravotnictví ČR. Je největším zdravotnickým zařízením v Olomouckém kraji a šestou největší nemocnicí v zemi. Její historie je více než stoletá, sahá do roku 1896. Fakultní nemocnice Olomouc je špičkovým centrem v mnoha oborech současné medicíny. Významně působí i v oblasti vědy a výzkumu a vzdělávání budoucích zdravotníků. Nemocnice je součástí národní sítě komplexních onkologických, hematoonkologických a traumatologických center."

During the past decade, Fakultni nemocnice Olomouc conducted 158 clinical trials. In the 10-year time frame, 158 clinical trials started and 86 clinical trials were completed, i.e. on average, 54.4% percent of trials that started reached the finish line to date. In the past 5 years, 72 clinical trials started and 53 clinical trials were completed. i.e. 73.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fakultni nemocnice Olomouc" #1 sponsor was "Pfizer" with 22 trials, followed by "Hoffmann-La Roche" with 11 trials sponsored, "University Hospital Olomouc" with 11 trials sponsored, "Amgen" with 7 trials sponsored and "Boehringer Ingelheim" with 7 trials sponsored. Other sponsors include 188 different institutions and companies that sponsored additional 124 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni nemocnice Olomouc" #1 collaborator was "University Hospital Olomouc" with 7 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 91 different institutions and companies that were collaborators in the rest 92 trials.

According to Clinical.Site data, the most researched conditions in "Fakultni nemocnice Olomouc" are "Multiple Myeloma" (12 trials), "Prostate Cancer" (7 trials), "Chronic Lymphocytic Leukemia" (5 trials), "Heart Failure" (5 trials) and "Leukemia" (5 trials). Many other conditions were trialed in "Fakultni nemocnice Olomouc" in a lesser frequency.

Most popular intervention types in "Fakultni nemocnice Olomouc" are "Drug" (187 trials), "Biological" (28 trials), "Device" (23 trials), "Other" (18 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (49 trials), "Dexamethasone" (10 trials), "Rituximab" (10 trials), "Paclitaxel" (9 trials) and "Cisplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Fakultni nemocnice Olomouc" are 226 trials for "All" genders, 15 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 95 active trials in "Fakultni nemocnice Olomouc". 4 are not yet recruiting, 53 are recruiting, 37 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 120 completed trials in Fakultni nemocnice Olomouc, undefined suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultni nemocnice Olomouc, 9 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 144 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 17 trials that are defined as “Not Applicable".

Fakultni nemocnice Olomouc has several departments that took part in Clinical trials: "Fakultni nemocnice Olomouc; Onkologicka klinika" - 41 trials, "Fakultni nemocnice Olomouc; Pneumologicka klinika" - 5 trials, "Fakultni nemocnice Olomouc, Neurologicka klinika" - 5 trials, "University Hospital Olomouc, Clinic of Hemato-Oncology" - 4 trials, "Fakultni Nemocnice Olomouc, Hemato-Onkologicka Klinika" - 3 trials, "Dept. of NephrologyIII. Clinic of Internal DiseasesUniversity Hospital I.P.Pavlova" - 2 trials